Eva Žusinaite

2.2k total citations
45 papers, 931 citations indexed

About

Eva Žusinaite is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Eva Žusinaite has authored 45 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 17 papers in Public Health, Environmental and Occupational Health and 12 papers in Epidemiology. Recurrent topics in Eva Žusinaite's work include Mosquito-borne diseases and control (16 papers), Viral Infections and Vectors (10 papers) and HIV Research and Treatment (8 papers). Eva Žusinaite is often cited by papers focused on Mosquito-borne diseases and control (16 papers), Viral Infections and Vectors (10 papers) and HIV Research and Treatment (8 papers). Eva Žusinaite collaborates with scholars based in Estonia, Finland and Norway. Eva Žusinaite's co-authors include Andres Merits, Kai Rausalu, Eric J. Snijder, Irina C. Albulescu, Florine E. M. Scholte, Martijn J. van Hemert, Ali Taş, Magnar Bjørås, Aleksandr Ianevski and Tanel Tenson and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Eva Žusinaite

43 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Žusinaite Estonia 17 448 337 260 154 136 45 931
Katherine Basore United States 13 552 1.2× 591 1.8× 129 0.5× 183 1.2× 104 0.8× 24 889
Chia-Yi Yu Taiwan 19 651 1.5× 673 2.0× 444 1.7× 279 1.8× 422 3.1× 37 1.5k
Fabiana A. Carneiro Brazil 14 275 0.6× 261 0.8× 264 1.0× 158 1.0× 70 0.5× 25 789
Alain Jouan France 14 613 1.4× 537 1.6× 225 0.9× 131 0.9× 166 1.2× 18 1.2k
L Kabilan India 18 309 0.7× 617 1.8× 188 0.7× 104 0.7× 217 1.6× 42 942
Alex Chao United States 12 298 0.7× 379 1.1× 404 1.6× 80 0.5× 100 0.7× 23 962
Vijaya Satchidanandam India 20 612 1.4× 598 1.8× 258 1.0× 172 1.1× 147 1.1× 37 1.1k
Margherita Pezzullo Italy 16 423 0.9× 194 0.6× 274 1.1× 45 0.3× 23 0.2× 19 832
Fernando Valiente‐Echeverría Chile 24 447 1.0× 94 0.3× 710 2.7× 112 0.7× 187 1.4× 54 1.3k
Dhiraj Acharya United States 20 621 1.4× 288 0.9× 388 1.5× 193 1.3× 492 3.6× 32 1.3k

Countries citing papers authored by Eva Žusinaite

Since Specialization
Citations

This map shows the geographic impact of Eva Žusinaite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Žusinaite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Žusinaite more than expected).

Fields of papers citing papers by Eva Žusinaite

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Žusinaite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Žusinaite. The network helps show where Eva Žusinaite may publish in the future.

Co-authorship network of co-authors of Eva Žusinaite

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Žusinaite. A scholar is included among the top collaborators of Eva Žusinaite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Žusinaite. Eva Žusinaite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Legrand, Alexandre, et al.. (2025). SAMD9L inhibits flavivirus translation independently of its capacity to trigger innate immune response. PLoS Pathogens. 21(12). e1013773–e1013773.
2.
Rausalu, Kai, Eva Žusinaite, Vambola Kisand, et al.. (2023). Antiviral efficacy of nanomaterial-treated textiles in real-life like exposure conditions. Heliyon. 9(9). e20067–e20067. 4 indexed citations
3.
Rausalu, Kai, Eva Žusinaite, A. S. Vanetsev, et al.. (2022). Antiviral efficacy of cerium oxide nanoparticles. Scientific Reports. 12(1). 18746–18746. 26 indexed citations
4.
Kubo, Anna‐Liisa, Kai Rausalu, Natalja Savest, et al.. (2022). Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus. Pharmaceutics. 14(12). 2549–2549. 23 indexed citations
5.
Ianevski, Aleksandr, Rouan Yao, Eva Žusinaite, et al.. (2022). Mono- and combinational drug therapies for global viral pandemic preparedness. iScience. 25(4). 104112–104112. 20 indexed citations
6.
Ianevski, Aleksandr, Eva Žusinaite, Tanel Tenson, et al.. (2022). Novel Synergistic Anti-Enteroviral Drug Combinations. Viruses. 14(9). 1866–1866. 8 indexed citations
7.
Tserel, Liina, Paul Naaber, Julia Maslovskaja, et al.. (2021). Long-Term Elevated Inflammatory Protein Levels in Asymptomatic SARS-CoV-2 Infected Individuals. Frontiers in Immunology. 12. 709759–709759. 16 indexed citations
8.
Ianevski, Aleksandr, Rouan Yao, Eva Žusinaite, et al.. (2021). Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study. Viruses. 13(8). 1537–1537. 3 indexed citations
9.
Ivanova, Larisa, Kai Rausalu, Eva Žusinaite, et al.. (2021). 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors. ACS Omega. 6(8). 5786–5794. 14 indexed citations
10.
Žusinaite, Eva, Liis Karo-Astover, Kai Rausalu, et al.. (2021). Semliki Forest Virus Chimeras with Functional Replicase Modules from Related Alphaviruses Survive by Adaptive Mutations in Functionally Important Hot Spots. Journal of Virology. 95(20). e0097321–e0097321. 5 indexed citations
11.
Soeorg, Hiie, Freddy Lättekivi, Paul Naaber, et al.. (2021). Prevalence of SARS-CoV-2 IgG antibodies and their association with clinical symptoms of COVID-19 in Estonia (KoroSero-EST-1 study). Vaccine. 39(38). 5376–5384. 7 indexed citations
12.
García‐Arriaza, Juan, Eva Žusinaite, Inga Szurgot, et al.. (2018). DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost. Scientific Reports. 8(1). 12459–12459. 20 indexed citations
13.
Mutso, Margit, Sirle Saul, Kai Rausalu, et al.. (2017). Reverse genetic system, genetically stable reporter viruses and packaged subgenomic replicon based on a Brazilian Zika virus isolate. Journal of General Virology. 98(11). 2712–2724. 67 indexed citations
14.
Rausalu, Kai, Age Utt, Finny S. Varghese, et al.. (2016). Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease’s active site cysteine residue. Scientific Reports. 6(1). 37124–37124. 52 indexed citations
15.
Mutso, Margit, Eva Žusinaite, Anastasia Selyutina, et al.. (2015). RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications. PLoS ONE. 10(6). e0128686–e0128686. 13 indexed citations
16.
Žusinaite, Eva, et al.. (2014). Development of a luciferase-based system for the detection of ZnT8 autoantibodies. Journal of Immunological Methods. 405. 67–73. 10 indexed citations
17.
Selyutina, Anastasia, Tõnis Pehk, Margus Lopp, et al.. (2011). Synthesis and Biological Activity of Bimorpholine and its Carbanucleoside. Nucleosides Nucleotides & Nucleic Acids. 30(11). 897–907. 6 indexed citations
18.
Paju, Anne, Anastasia Selyutina, Eva Žusinaite, et al.. (2010). Synthesis of Novel Acyclic Nucleoside Analogues with Anti-Retroviral Activity. Nucleosides Nucleotides & Nucleic Acids. 29(9). 707–720. 7 indexed citations
19.
Karo-Astover, Liis, et al.. (2010). The infection of mammalian and insect cells with SFV bearing nsP1 palmitoylation mutations. Virus Research. 153(2). 277–287. 11 indexed citations
20.
Žusinaite, Eva, Riina Salupere, Kai Zilmer, et al.. (2000). Hepatitis C virus genotypes in Estonia. Apmis. 108(11). 739–746. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine Basore Breakdown of academic impact, for papers by Chia-Yi Yu Breakdown of academic impact, for papers by Fabiana A. Carneiro Breakdown of academic impact, for papers by Alain Jouan Breakdown of academic impact, for papers by L Kabilan Breakdown of academic impact, for papers by Alex Chao Breakdown of academic impact, for papers by Vijaya Satchidanandam Breakdown of academic impact, for papers by Margherita Pezzullo Breakdown of academic impact, for papers by Fernando Valiente‐Echeverría Breakdown of academic impact, for papers by Dhiraj Acharya
Rankless by CCL
2026